SN · Pharma and healthcare · one day
Smith & Nephew (SN): news on Tuesday 27 October 2026
News from the 24 hours to Tuesday morning, 27 October 2026.
Tone of the day
What the score means. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Why it scored this way
Coverage centred on the collapse of talks with Johnson & Johnson to combine their orthopaedics businesses, which leans negative. A separate piece on the shares in a UK market rebound was mildly positive.
What drove it
- J&J deal collapse
- orthopaedics merger talks
- UK market rebound
Around this day
| Day | Tone | Headlines |
|---|---|---|
| Wed 21 Oct | +0.3 | 4 |
| Thu 22 Oct | +3.2 | 2 |
| Fri 23 Oct | −3.7 | 7 |
| Sat 24 Oct | −5.7 | 21 |
| Sun 25 Oct | −2.0 | 3 |
| Mon 26 Oct | −1.2 | 4 |
| Tue 27 Oct | −5.3 | 4 |
2 stories · 4 headlines · strongest first
Pharma and healthcare on 27 OctoberFTSE 100 that day| Tone | What the article reported, and why it scored that way | |
|---|---|---|
| Smith & Nephew's merger discussions with J&J's orthopaedics arm fall through −4.93 headlines today · 31 in all, since 23 October · Several outlets said Smith & Nephew and the orthopaedics arm of J&J failed to reach agreement in merger discussions. | ||
| −6.0 | Planned orthopaedics combination with J&J did not go ahead. | |
| −5.8 | Talks on combining orthopaedics businesses with J&J ended without agreement. | |
| −5.0 | Describes a failed large merger over leadership disagreement, apparently this deal. | |
| Smith & Nephew and UK market rebound commentary +1.71 headline today · Kalkine Media discussed Smith & Nephew amid a UK share rebound. | ||
| +1.7 | Profile piece on company's relevance as UK shares recover. | |
Each article has its own score. The lines are our own summary; follow the source link to read the article itself.
Follow by email
A short, free morning email on how the news treated Smith & Nephew: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.